nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antimony resistance and environment: Elusive links to explore during Leishmania life cycle
|
Sereno, Denis |
|
2012 |
2 |
C |
p. 200-203 4 p. |
artikel |
2 |
Application of a resazurin-based high-throughput screening assay for the identification and progression of new treatments for human African trypanosomiasis
|
Bowling, Tana |
|
2012 |
2 |
C |
p. 262-270 9 p. |
artikel |
3 |
A reappraisal of the relative sensitivity of nematode pharyngeal and somatic musculature to macrocyclic lactone drugs
|
Kotze, Andrew C. |
|
2012 |
2 |
C |
p. 29-35 7 p. |
artikel |
4 |
Artemisinin resistance in Plasmodium falciparum: A process linked to dormancy?
|
Cheng, Qin |
|
2012 |
2 |
C |
p. 249-255 7 p. |
artikel |
5 |
Chemotherapeutics challenges in developing effective treatments for the endemic malarias
|
Kevin Baird , J. |
|
2012 |
2 |
C |
p. 256-261 6 p. |
artikel |
6 |
Current treatment options for Dientamoeba fragilis infections
|
Nagata, Noriyuki |
|
2012 |
2 |
C |
p. 204-215 12 p. |
artikel |
7 |
CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds
|
Hargrove, Tatiana Y. |
|
2012 |
2 |
C |
p. 178-186 9 p. |
artikel |
8 |
Degrees of chloroquine resistance in Plasmodium – Is the redox system involved?
|
Lehane, Adele M. |
|
2012 |
2 |
C |
p. 47-57 11 p. |
artikel |
9 |
Di-cationic arylimidamides act against Neospora caninum tachyzoites by interference in membrane structure and nucleolar integrity and are active against challenge infection in mice
|
Schorer, Michelle |
|
2012 |
2 |
C |
p. 109-120 12 p. |
artikel |
10 |
Distribution patterns of three sodium channel mutations associated with pyrethroid resistance in Rhipicephalus (Boophilus) microplus populations from North and South America, South Africa and Australia
|
Lovis, Leonore |
|
2012 |
2 |
C |
p. 216-224 9 p. |
artikel |
11 |
Effects of the green tea catechin (−)-epigallocatechin gallate on Trypanosoma brucei
|
Vigueira, Patrick A. |
|
2012 |
2 |
C |
p. 225-229 5 p. |
artikel |
12 |
Genotypic analysis of β-tubulin in Onchocerca volvulus from communities and individuals showing poor parasitological response to ivermectin treatment
|
Osei-Atweneboana, Mike Y. |
|
2012 |
2 |
C |
p. 20-28 9 p. |
artikel |
13 |
Inhibitors of RNA editing as potential chemotherapeutics against trypanosomatid pathogens
|
Salavati, Reza |
|
2012 |
2 |
C |
p. 36-46 11 p. |
artikel |
14 |
In silico prediction of antimalarial drug target candidates
|
Ludin, Philipp |
|
2012 |
2 |
C |
p. 191-199 9 p. |
artikel |
15 |
Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults?
|
van Hellemond, Jaap J. |
|
2012 |
2 |
C |
p. 162-165 4 p. |
artikel |
16 |
Monitoring antimalarial drug resistance: Applying lessons learned from the past in a fast-moving present
|
Sibley, Carol Hopkins |
|
2012 |
2 |
C |
p. 126-133 8 p. |
artikel |
17 |
Moxidectin and the avermectins: Consanguinity but not identity
|
Prichard, Roger |
|
2012 |
2 |
C |
p. 134-153 20 p. |
artikel |
18 |
Nitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination
|
Tritten, Lucienne |
|
2012 |
2 |
C |
p. 98-105 8 p. |
artikel |
19 |
Nitroimidazole drugs vary in their mode of action in the human parasite Giardia lamblia
|
Leitsch, David |
|
2012 |
2 |
C |
p. 166-170 5 p. |
artikel |
20 |
Oxadiazole 2-oxides are toxic to the human hookworm, Ancylostoma ceylanicum, however glutathione reductase is not the primary target
|
Treger, Rebecca S. |
|
2012 |
2 |
C |
p. 171-177 7 p. |
artikel |
21 |
Parasite neuropeptide biology: Seeding rational drug target selection?
|
McVeigh, Paul |
|
2012 |
2 |
C |
p. 76-91 16 p. |
artikel |
22 |
P-glycoproteins and other multidrug resistance transporters in the pharmacology of anthelmintics: Prospects for reversing transport-dependent anthelmintic resistance
|
Lespine, Anne |
|
2012 |
2 |
C |
p. 58-75 18 p. |
artikel |
23 |
Pharmacokinetics of the fasciocidal drug candidates MT04 and OZ78 in uninfected rats and in vitro pharmacodynamic studies
|
Kirchhofer, Carla |
|
2012 |
2 |
C |
p. 121-125 5 p. |
artikel |
24 |
Recent developments in sterol 14-demethylase inhibitors for Chagas disease
|
Buckner, Frederick S. |
|
2012 |
2 |
C |
p. 236-242 7 p. |
artikel |
25 |
Recent highlights in anti-protozoan drug development and resistance research
|
Buckner, Frederick S. |
|
2012 |
2 |
C |
p. 230-235 6 p. |
artikel |
26 |
Relative level of thiabendazole resistance associated with the E198A and F200Y SNPs in larvae of a multi-drug resistant isolate of Haemonchus contortus
|
Kotze, Andrew C. |
|
2012 |
2 |
C |
p. 92-97 6 p. |
artikel |
27 |
Teladorsagia circumcincta: Molecular characterisation of the avr-14B subunit and its relatively minor role in ivermectin resistance
|
Martínez-Valladares, María |
|
2012 |
2 |
C |
p. 154-161 8 p. |
artikel |
28 |
The Entamoeba histolytica serum-inducible transmembrane kinase EhTMKB1-9 is involved in intestinal amebiasis
|
Abhyankar, Mayuresh M. |
|
2012 |
2 |
C |
p. 243-248 6 p. |
artikel |
29 |
The proteasome of malaria parasites: A multi-stage drug target for chemotherapeutic intervention?
|
Aminake, Makoah Nigel |
|
2012 |
2 |
C |
p. 1-10 10 p. |
artikel |
30 |
Visceral leishmaniasis treatment: What do we have, what do we need and how to deliver it?
|
Freitas-Junior, Lucio H. |
|
2012 |
2 |
C |
p. 11-19 9 p. |
artikel |
31 |
Worming our way closer to the clinic
|
Hepworth, Matthew R. |
|
2012 |
2 |
C |
p. 187-190 4 p. |
artikel |
32 |
Worm therapy: How would you like your medicine?
|
Pritchard, David I. |
|
2012 |
2 |
C |
p. 106-108 3 p. |
artikel |